• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Studio
  • Genomics
  • Solutions
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • Newsroom
    • Careers
Get started
Sign in
#REpharmaUSA 2022: Empowering pharma with real-time access to the USA’s medical records

#REpharmaUSA 2022: Empowering pharma with real-time access to the USA’s medical records

by Truveta staff | Mar 16, 2022 | News

Today Truveta CEO Terry Myerson talked with leaders from across the pharmaceutical industry at Reuters’ Pharma USA 2022 (#REpharmaUSA) in Philadelphia during a keynote presentation, sharing how we can work together to transform healthcare. In Myerson’s keynote, he...

Share this


Recent posts

  • New study finds GLP-1 RA medications may significantly reduce risk of alcohol-related hospitalization
  • Understanding the impact of the COVID-19 pandemic on childhood MMR vaccination patterns
  • Shifting trends in TKA fixation: Real-world evidence on the changing landscape of cemented vs uncemented TKA

Follow Truveta


Sign up for our newsletter

Ready to accelerate your research with representative, complete, and timely real-world data?

Truveta Data

Truveta Genome Project

Solutions

Research

Resources

Blog

Newsroom

Careers

Privacy notice

Contact us

© Truveta 2025

Our website uses cookies to ensure you have the best experience.AcceptPrivacy notice